Does ABIRATERONE Cause Prostate cancer? 661 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 661 reports of Prostate cancer have been filed in association with ABIRATERONE (Abiraterone Acetate). This represents 1.9% of all adverse event reports for ABIRATERONE.
661
Reports of Prostate cancer with ABIRATERONE
1.9%
of all ABIRATERONE reports
267
Deaths
163
Hospitalizations
How Dangerous Is Prostate cancer From ABIRATERONE?
Of the 661 reports, 267 (40.4%) resulted in death, 163 (24.7%) required hospitalization, and 15 (2.3%) were considered life-threatening.
Is Prostate cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ABIRATERONE. However, 661 reports have been filed with the FAERS database.
What Other Side Effects Does ABIRATERONE Cause?
Death (5,623)
Fatigue (1,928)
Drug ineffective (1,732)
Therapy cessation (1,602)
Prostatic specific antigen increased (1,581)
Disease progression (1,098)
Hospitalisation (1,034)
Hot flush (989)
Asthenia (891)
Off label use (859)
What Other Drugs Cause Prostate cancer?
RANITIDINE (60,641)
LEUPROLIDE (1,736)
ENZALUTAMIDE (642)
ADALIMUMAB (573)
ETANERCEPT (482)
METHOTREXATE (444)
INFLIXIMAB (376)
LENALIDOMIDE (366)
PREDNISONE (317)
RITUXIMAB (317)
Which ABIRATERONE Alternatives Have Lower Prostate cancer Risk?
ABIRATERONE vs ABIRATERONE\ABIRATERONE
ABIRATERONE vs ABOBOTULINUMTOXINA
ABIRATERONE vs ABRAXANE
ABIRATERONE vs ABROCITINIB
ABIRATERONE vs ACALABRUTINIB